Filing Details
- Accession Number:
- 0001127602-12-009525
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-05 15:38:32
- Reporting Period:
- 2012-03-01
- Filing Date:
- 2012-03-05
- Accepted Time:
- 2012-03-05 15:38:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882796 | Biocryst Pharmaceuticals Inc | BCRX | Biological Products, (No Disgnostic Substances) (2836) | 621413174 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1439174 | P William Sheridan | 4505 Emperor Blvd. Suite 200 Durham NC 27703 | Sr Vp - Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-03-01 | 8,500 | $0.00 | 30,286 | No | 4 | A | Direct | |
Common Stock | Disposition | 2012-03-02 | 956 | $4.78 | 29,330 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Emp. Stock Option (Right to Buy) | Acquisiton | 2012-03-01 | 50,000 | $4.73 | 50,000 | $4.73 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
50,000 | 2013-03-01 | 2022-03-01 | No | 4 | A | Direct |
Footnotes
- Restricted Stock Award-25% vest per year